Generic AML drug shows promise in bioequivalence study

This study tested whether a generic version of the drug azacitidine works the same as the brand-name drug Onureg® in adults with acute myeloid leukemia (AML). Thirty-two participants who were in remission after initial chemotherapy took single doses of both tablets under fasting conditions. The goal was to compare how the drugs are absorbed and processed by the body, which helps ensure the generic is a safe and effective alternative for maintenance therapy.